RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Philadelphia, PA · Pittsburgh, PA · +49 more sites
Psoriasis clinical trials in Philadelphia, PA
11 recruiting psoriasis studies with a site in Philadelphia, PA.
RecruitingPhase 2NCT07013201
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Sponsor: LEO Pharma
Philadelphia, PA · +6 more sites
RecruitingPhase 3NCT06807424
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Sponsor: Janssen Research & Development, LLC
Duncansville, PA · Philadelphia, PA · +23 more sites
RecruitingPhase 2NCT07321873
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Sponsor: Janssen Research & Development, LLC
Philadelphia, PA · +17 more sites
RecruitingPhase 2NCT07486960
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Sponsor: Merck Sharp & Dohme LLC
Duncansville, PA · Philadelphia, PA · +16 more sites
RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Philadelphia, PA · +46 more sites
RecruitingPhase not listedNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor: Duke University
Hershey, PA · Philadelphia, PA · +72 more sites
RecruitingPhase 2NCT07489885
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
Philadelphia, PA · +19 more sites
RecruitingPhase 4NCT06454188
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Sponsor: CARE ARTHRITIS LTD.
Philadelphia, PA · +2 more sites
RecruitingPhase 3NCT05669833
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Sponsor: University of Pennsylvania
Philadelphia, PA · +13 more sites
RecruitingPhase 1NCT05642182
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
Sponsor: SFA Therapeutics
Philadelphia, PA · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.